128 related articles for article (PubMed ID: 16519149)
1. [Establishment of bone metastasis model of prostate cancer in nude mice by intratibia injection of human prostate cancer cell line Du145].
Luo Y; Zhang LL; Ning L; He DL; Fan JH; Hou HL
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):133-6. PubMed ID: 16519149
[TBL] [Abstract][Full Text] [Related]
2. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
3. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
Singh AS; Macpherson GR; Price DK; Schimel D; Figg WD
Oncol Rep; 2006 Mar; 15(3):519-24. PubMed ID: 16465406
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
6. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential].
Liu YB; He XW; Wang JW; Li JT; Li KQ; Liu FB; Xue JF; Zhu JH; Li B; Peng SY
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2117-21. PubMed ID: 17064616
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of metastatic potential in prostate carcinoma: an in vivo model.
Angelucci A; Gravina GL; Rucci N; Festuccia C; Muzi P; Vicentini C; Teti A; Bologna M
Int J Oncol; 2004 Dec; 25(6):1713-20. PubMed ID: 15547709
[TBL] [Abstract][Full Text] [Related]
9. Development of an animal model for prostate cancer cell metastasis to adult human bone.
Tsingotjidou AS; Zotalis G; Jackson KR; Sawyers C; Puzas JE; Hicks DG; Reiter R; Lieberman JR
Anticancer Res; 2001; 21(2A):971-8. PubMed ID: 11396190
[TBL] [Abstract][Full Text] [Related]
10. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
11. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG
Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
[TBL] [Abstract][Full Text] [Related]
12. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
[TBL] [Abstract][Full Text] [Related]
13. An in vivo model of prostate carcinoma growth and invasion in bone.
Fisher JL; Schmitt JF; Howard ML; Mackie PS; Choong PF; Risbridger GP
Cell Tissue Res; 2002 Mar; 307(3):337-45. PubMed ID: 11904770
[TBL] [Abstract][Full Text] [Related]
14. Comparative intraosseal growth of human prostate cancer cell lines LNCaP and PC-3 in the nude mouse.
Soos G; Jones RF; Haas GP; Wang CY
Anticancer Res; 1997; 17(6D):4253-8. PubMed ID: 9494517
[TBL] [Abstract][Full Text] [Related]
15. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
[TBL] [Abstract][Full Text] [Related]
16. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; RĂ©dini F
Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
[TBL] [Abstract][Full Text] [Related]
17. A fluorescent orthotopic bone metastasis model of human prostate cancer.
Yang M; Jiang P; Sun FX; Hasegawa S; Baranov E; Chishima T; Shimada H; Moossa AR; Hoffman RM
Cancer Res; 1999 Feb; 59(4):781-6. PubMed ID: 10029062
[TBL] [Abstract][Full Text] [Related]
18. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
Thalmann GN; Anezinis PE; Chang SM; Zhau HE; Kim EE; Hopwood VL; Pathak S; von Eschenbach AC; Chung LW
Cancer Res; 1994 May; 54(10):2577-81. PubMed ID: 8168083
[TBL] [Abstract][Full Text] [Related]
19. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
Tsingotjidou AS; Ahluwalia R; Zhang X; Conrad H; Emmanouilides C
Int J Oncol; 2003 Dec; 23(6):1569-74. PubMed ID: 14612928
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]